1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ERASCA INC
Erasca Inc
XNAS: ERAS
Download real time
16.03 0.33 (2.10%)
33.98% Fall from 52W High
8.2M
XNAS Volume
High volume today

XNAS 10 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for Erasca Inc

The latest disclosure was made by Charles S. Fuchs in Erasca Inc where a trade of 1,300,000 Stock option (right to buy) done was reported to US exchanges on Aug. 10, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Charles S. Fuchs President, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2026 1,300,000 1,300,000 - - Stock option (right to buy)
Alexander W. Casdin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 29,888 29,888 - - Stock option (right to buy)
Jean I. Liu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 29,888 29,888 - - Stock option (right to buy)
Julie Hambleton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 29,888 29,888 - - Stock option (right to buy)
Pratik S. Multani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 29,888 29,888 - - Stock option (right to buy)
James A. Bristol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 29,888 29,888 - - Stock option (right to buy)
Valerie Harding Start Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2026 29,888 29,888 - - Stock option (right to buy)
Ebun S. Garner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. 01 Apr 2026 80,000 105,076 - 1.7 136,000 Common Stock
Ebun S. Garner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2026 80,000 280,000 - - Stock Option (right to buy)
Ebun S. Garner Chief Legal Officer Sale of securities on an exchange or to another person at price $ 16.40 per share. 01 Apr 2026 80,000 25,076 - 16.4 1,312,000 Common Stock
Shannon R. Morris Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Mar 2026 20,000 515,800 - - Stock Option (right to buy)
Shannon R. Morris Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.04 per share. 04 Mar 2026 20,000 0 - 15.0 300,760 Common Stock
Shannon R. Morris Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. 04 Mar 2026 20,000 20,000 - 1.7 34,000 Common Stock
Ebun S. Garner General Counsel & Corp. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2026 560,000 560,000 - - Stock option (right to buy)
Jonathan E. Lim Director, Chairman & CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2026 2,000,000 2,000,000 - - Stock option (right to buy)
Michael D. Varney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2026 96,000 96,000 - - Stock option (right to buy)
Shannon R. Morris Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2026 625,000 625,000 - - Stock option (right to buy)
Alexander W. Casdin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2026 23,872 23,872 - - Stock Option (right to buy)
Jean I. Liu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2026 20,617 20,617 - - Stock Option (right to buy)
Pratik S. Multani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2026 19,532 19,532 - - Stock Option (right to buy)
James A. Bristol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2026 37,762 37,762 - - Stock Option (right to buy)
Valerie Harding Start Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2026 24,306 24,306 - - Stock Option (right to buy)
Ebun S. Garner General Counsel & Corp. Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2025 120,000 360,000 - - Stock Option (right to buy)
Ebun S. Garner General Counsel & Corp. Sec. Sale of securities on an exchange or to another person at price $ 5.59 per share. 15 Dec 2025 120,000 25,076 - 5.6 670,812 Common Stock
Ebun S. Garner General Counsel & Corp. Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. 15 Dec 2025 120,000 145,076 - 1.7 204,000 Common Stock
Ebun S. Garner General Counsel & Corp. Sec. Grant, award, or other acquisition of securities at price $ 1.19 per share. 15 Dec 2025 3,902 25,076 - 1.2 4,660 Common Stock
David M. Chacko CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2025 640,000 640,000 - - Stock option (right to buy)
David M. Chacko CFO and CBO Other type of transaction at price $ 1.19 per share. 15 Dec 2025 17,793 279,980 - 1.2 21,250 Common Stock
Alexander W. Casdin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2025 120,000 120,000 - - Stock option (right to buy)
Jean I. Liu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2025 120,000 120,000 - - Stock option (right to buy)
Julie Hambleton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2025 120,000 120,000 - - Stock option (right to buy)
Pratik S. Multani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2025 120,000 120,000 - - Stock option (right to buy)
James A. Bristol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2025 120,000 120,000 - - Stock option (right to buy)
Michael D. Varney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2025 120,000 120,000 - - Stock option (right to buy)
Valerie Harding Start Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2025 120,000 120,000 - - Stock option (right to buy)
Pratik S. Multani Director Gift of securities by or to the insider at price $ 0.00 per share. 23 May 2025 6,200 6,200 - 0 Common Stock
Pratik S. Multani Director Gift of securities by or to the insider at price $ 0.00 per share. 23 May 2025 6,200 166,666 - 0 Common Stock
Ebun S. Garner General Counsel & Corp. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 50,000 50,000 - - Stock option (right to buy)
Ebun S. Garner General Counsel & Corp. Sec. Other type of transaction at price $ 1.56 per share. 03 Feb 2025 5,715 21,174 - 1.6 8,938 Common Stock
Ebun S. Garner General Counsel & Corp. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 700,000 700,000 - - Stock option (right to buy)
Ebun S. Garner General Counsel & Corp. Sec. Other type of transaction at price $ 1.56 per share. 03 Feb 2025 5,731 21,174 - 1.6 8,963 Common Stock
Jonathan E. Lim Director, Chairman & CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 2,500,000 2,500,000 - - Stock option (right to buy)
Shannon R. Morris Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 780,000 780,000 - - Stock option (right to buy)
David M. Chacko CFO and CBO Other type of transaction at price $ 1.56 per share. 03 Feb 2025 3,137 262,187 - 1.6 4,906 Common Stock
David M. Chacko CFO and CBO Other type of transaction at price $ 1.56 per share. 03 Feb 2025 12,324 262,187 - 1.6 19,275 Common Stock
David M. Chacko CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 800,000 800,000 - - Stock option (right to buy)
Valerie Harding Start Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 29,402 29,402 - - Stock Option (right to buy)
James Bristol A. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 45,678 45,678 - - Stock Option (right to buy)
Liu Jean I. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 24,939 24,939 - - Stock Option (right to buy)
Alexander W. Casdin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 28,877 28,877 - - Stock Option (right to buy)
Alexander W. Casdin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Ebun S. Garner General Counsel & Corp. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 160,082 160,082 - - Stock Option (right to buy)
Jean I. Liu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Jonathan E. Lim Director, Chairman & CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 632,759 632,759 - - Stock Option (right to buy)
Julie Hambleton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Pratik S. Multani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
James A. Bristol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Michael D. Varney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Valerie Harding Start Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Shannon R. Morris Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 137,142 137,142 - - Stock Option (right to buy)
David M. Chacko CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 278,812 278,812 - - Stock Option (right to buy)
Alexander W. Casdin Director Purchase of securities on an exchange or from another person at price $ 2.27 per share. 21 May 2024 80,000 573,974 - 2.3 181,920 Common Stock
Shannon Morris Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2024 535,800 535,800 - - Stock Option (right to buy)
M. Chacko David CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2024 600,000 600,000 - - Stock Option (right to buy)
Lim E. Jonathan Director, Chairman & CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2024 1,500,000 1,500,000 - - Stock Option (right to buy)
S. Garner Ebun General Counsel & Corp. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2024 480,000 480,000 - - Stock Option (right to buy)
Liu Jean I. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 35,482 35,482 - - Stock Option (right to buy)
S. Multani Pratik Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 32,867 32,867 - - Stock Option (right to buy)
James Bristol A. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 62,747 62,747 - - Stock Option (right to buy)
Harding Start Valerie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 39,590 39,590 - - Stock Option (right to buy)
Alexander Casdin W. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 41,084 41,084 - - Stock Option (right to buy)
S. Ebun Garner General Counsel & Corp. Sec. Other type of transaction at price $ 1.59 per share. 15 Dec 2023 5,448 9,728 - 1.6 8,660 Common Stock
M. Chacko David CFO and CBO Other type of transaction at price $ 1.59 per share. 15 Dec 2023 7,478 246,726 - 1.6 11,886 Common Stock
Harding Start Valerie Director Purchase of securities on an exchange or from another person at price $ 1.85 per share. 06 Dec 2023 10,000 20,000 - 1.8 18,480 Common Stock
Jonathan Lim E. Director, Chairman & CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.69 per share. 05 Dec 2023 721,850 12,899,360 - 1.7 1,217,761 Common Stock
Lim E. Jonathan Director, Chairman & CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.72 per share. 05 Dec 2023 278,150 12,899,360 - 1.7 478,418 Common Stock
Alexander W. Casdin Director Purchase of securities on an exchange or from another person at price $ 1.66 per share. 04 Dec 2023 30,000 493,974 - 1.7 49,785 Common Stock
Alexander W. Casdin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 60,000 60,000 - - Stock Option (right to buy)
Jean I. Liu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 60,000 60,000 - - Stock Option (right to buy)
Julie Hambleton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 60,000 60,000 - - Stock Option (right to buy)
Pratik S. Multani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 60,000 60,000 - - Stock Option (right to buy)
James A. Bristol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 60,000 60,000 - - Stock Option (right to buy)
Michael D. Varney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 60,000 60,000 - - Stock Option (right to buy)
Valerie Harding Start Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 60,000 60,000 - - Stock Option (right to buy)
Bihua Chen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 60,000 60,000 - - Stock Option (right to buy)
Jonathan E. Lim Director, Chairman & CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.75 per share. 08 Jun 2023 100,000 18,396,216 - 2.8 275,000 Common Stock
Alexander W. Casdin Director Purchase of securities on an exchange or from another person at price $ 2.76 per share. 10 Apr 2023 20,000 463,974 - 2.8 55,230 Common Stock
Shannon Morris Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2023 375,000 375,000 - - Stock Option (Right to Buy)
Ebun S. Garner General Counsel & Corp. Sec. Other type of transaction at price $ 4.10 per share. 01 Feb 2023 2,388 4,280 - 4.1 9,784 Common Stock
Ebun S. Garner General Counsel & Corp. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 480,000 480,000 - - Stock Option (right to buy)
Ebun S. Garner General Counsel & Corp. Sec. Other type of transaction at price $ 4.00 per share. 01 Feb 2023 2 4,280 - 4 8 Common Stock
Jonathan E. Lim Director, Chairman & CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 1,500,000 1,500,000 - - Stock Option (right to buy)
David M. Chacko Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 600,000 600,000 - - Stock Option (right to buy)
David M. Chacko Chief Financial Officer Other type of transaction at price $ 4.00 per share. 01 Feb 2023 2 239,248 - 4 8 Common Stock
David M. Chacko Chief Financial Officer Other type of transaction at price $ 4.10 per share. 01 Feb 2023 1,748 239,248 - 4.1 7,162 Common Stock
Wei Lin Chief Medical Officer Other type of transaction at price $ 4.00 per share. 01 Feb 2023 2 315,812 - 4 8 Common Stock
Wei Lin Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 560,000 560,000 - - Stock Option (right to buy)
Wei Lin Chief Medical Officer Other type of transaction at price $ 4.10 per share. 01 Feb 2023 1,748 315,812 - 4.1 7,162 Common Stock
Jonathan E. Lim Director, Chairman & CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.86 per share. 10 Jan 2023 60,000 20,256,222 - 3.9 231,420 Common Stock
Jonathan E. Lim Director, Chairman and CEO, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2022 2,000,006 18,196,216 - 0 Common Stock
James A. Bristol Director Purchase of securities on an exchange or from another person at price $ 4.14 per share. 21 Dec 2022 20,000 20,000 - 4.1 82,800 Common Stock
Valerie Harding Start Director Purchase of securities on an exchange or from another person at price $ 4.64 per share. 21 Dec 2022 10,000 10,000 - 4.6 46,400 Common Stock
Alexander W. Casdin Director Purchase of securities on an exchange or from another person at price $ 4.87 per share. 15 Dec 2022 20,000 443,974 - 4.9 97,490 Common Stock
Jonathan E. Lim Director, Chairman & CEO, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 4.99 per share. 14 Dec 2022 40,000 20,196,222 - 5.0 199,600 Common Stock
Bihua Chen Director Purchase of securities on an exchange or from another person at price $ 6.50 per share. 13 Dec 2022 307,692 10,813,246 - 6.5 1,999,998 Common Stock
Alexander W. Casdin Director Other type of transaction at price $ 0.00 per share. 01 Jul 2022 750,000 0 - 0 Common Stock
Alexander W. Casdin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 40,000 40,000 - - Stock Option (right to buy)
Julie Hambleton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 40,000 40,000 - - Stock Option (right to buy)
Pratik S. Multani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 40,000 40,000 - - Stock Option (right to buy)
James A. Bristol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 40,000 40,000 - - Stock Option (right to buy)
Michael D. Varney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 60,000 60,000 - - Stock Option (right to buy)
Valerie Harding Start Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 40,000 40,000 - - Stock Option (right to buy)
Bihua Chen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 40,000 40,000 - - Stock Option (right to buy)
Jean I. Liu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2022 80,000 80,000 - - Stock Option (Right to Buy)
Ebun S. Garner General Counsel & Corp. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 171,110 171,110 - - Stock Option (Right to Buy)
Ebun S. Garner General Counsel & Corp. Sec. Other type of transaction at price $ 11.60 per share. 01 Feb 2022 990 1,890 - 11.6 11,486 Common Stock
Jonathan E. Lim Director, Chairman & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 791,000 791,000 - - Stock Option (Right to Buy)
David M. Chacko Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 366,125 366,125 - - Stock Option (Right to Buy)
David M. Chacko Chief Financial Officer Other type of transaction at price $ 11.60 per share. 01 Feb 2022 1,562 237,498 - 11.6 18,123 Common Stock
Wei Lin Chief Medical Officer Other type of transaction at price $ 11.60 per share. 01 Feb 2022 1,562 314,062 - 11.6 18,123 Common Stock
Wei Lin Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 272,100 272,100 - - Stock Option (Right to Buy)
Bihua Chen Director Sale of securities on an exchange or to another person at price $ 18.76 per share. 26 Jul 2021 200,000 10,305,553 - 18.8 3,753,000 Common Stock
Bihua Chen Director Purchase of securities on an exchange or from another person at price $ 22.10 per share. 26 Jul 2021 200,000 10,505,553 - 22.1 4,420,000 Common Stock
Alexander W. Casdin Director 20 Jul 2021 900,000 0 - - Series A Preferred Stock
Alexander W. Casdin Director 20 Jul 2021 150,000 337,500 - - Common Stock
Alexander W. Casdin Director 20 Jul 2021 750,000 750,000 - - Common Stock
Alexander W. Casdin Director 20 Jul 2021 180,000 0 - - Series A Preferred Stock
Ebun S. Garner General Counsel Purchase of securities on an exchange or from another person at price $ 16.00 per share. 20 Jul 2021 900 900 - 16 14,400 Common Stock
Jonathan E. Lim Director, See Remarks, Ten Percent Owner 20 Jul 2021 5,135,390 20,156,222 - - Common Stock
Jonathan E. Lim Director, See Remarks, Ten Percent Owner 20 Jul 2021 112,000 0 - - Series B-2 Preferred Stock
Jonathan E. Lim Director, See Remarks, Ten Percent Owner 20 Jul 2021 6,162,468 0 - - Series A Preferred Stock
Jonathan E. Lim Director, See Remarks, Ten Percent Owner 20 Jul 2021 6,081,233 0 - - Series A Preferred Stock
Jonathan E. Lim Director, See Remarks, Ten Percent Owner 20 Jul 2021 336,000 0 - - Series B-1 Preferred Stock
Jonathan E. Lim Director, See Remarks, Ten Percent Owner 20 Jul 2021 5,441,027 11,899,360 - - Common Stock
Julie Hambleton Director Purchase of securities on an exchange or from another person at price $ 16.00 per share. 20 Jul 2021 6,000 6,000 - 16 96,000 Common Stock
Pratik S. Multani Director Purchase of securities on an exchange or from another person at price $ 16.00 per share. 20 Jul 2021 6,200 172,866 - 16 99,200 Common Stock
Valerie Harding Start Director Purchase of securities on an exchange or from another person at price $ 16.00 per share. 20 Jul 2021 2,000 2,000 - 16 32,000 Common Stock
Bihua Chen Director Purchase of securities on an exchange or from another person at price $ 16.00 per share. 20 Jul 2021 950,000 10,505,553 - 16 15,200,000 Common Stock
Bihua Chen Director 20 Jul 2021 9,555,553 9,555,553 - - Common Stock
Bihua Chen Director 20 Jul 2021 1,388,887 0 - - Series B-2 Convertible Preferred Stock
Bihua Chen Director 20 Jul 2021 4,166,666 0 - - Series B-1 Convertible Preferred Stock
Bihua Chen Director 20 Jul 2021 4,000,000 0 - - Series A Convertible Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters